Comera Life Sciences Holdings, Inc. filed its 10-K on Mar 17, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0229 USD | -21.71% | -21.84% | -58.36% |
30/01 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
30/01 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
1st Jan change | Capi. | |
---|---|---|
-58.36% | 9L | |
+54.05% | 6.39TCr | |
-2.02% | 4.18TCr | |
+40.01% | 4.05TCr | |
-10.22% | 2.72TCr | |
+13.42% | 2.65TCr | |
-21.60% | 1.87TCr | |
+2.89% | 1.27TCr | |
+22.40% | 1.21TCr | |
+27.49% | 1.21TCr |
- Stock Market
- Equities
- CMRA Stock
- News Comera Life Sciences Holdings, Inc.
- Comera Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt